BAUDETTE, Minn., Oct. 27, 2016 /PRNewswire/ -- ANI
Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the
Company plans to release its third quarter and year-to-date 2016
financial results on Thursday, November 3,
2016, before the opening of the U.S. financial markets. The
earnings press release will be accessible through the Investor
Relations section of the Company's website,
www.anipharmaceuticals.com.
Arthur S. Przybyl, President and
Chief Executive Officer, and Stephen P.
Carey, Vice President, Finance, and Chief Financial Officer,
also plan to host a conference call to review those results
starting at 10:30am Eastern Time on
Thursday, November 3, 2016. The call
will be open to the public and can be accessed through a conference
line by dialing (866) 776-8875. The conference ID is 93840986.
A recording of the conference call will be available within two
hours of the completion of the call and will remain accessible for
a period of seven days following the call. To access the replay,
dial (800) 585-8367. The access code for the replay is
93840986.
About ANI
ANI Pharmaceuticals, Inc. (the "Company" or "ANI") is an
integrated specialty pharmaceutical company developing,
manufacturing, and marketing branded and generic prescription
pharmaceuticals. The Company's targeted areas of product
development currently include controlled substances, oncolytics
(anti-cancers), hormones and steroids, and complex formulations
involving extended release and combination products. For more
information, please visit our website
www.anipharmaceuticals.com.
For more information about ANI, please contact:
Investor Relations
IR@anipharmaceuticals.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/ani-pharmaceuticals-schedules-conference-call-to-discuss-third-quarter-and-year-to-date-2016-financial-results-300352308.html
SOURCE ANI Pharmaceuticals, Inc.